Targeting severe symptoms of early 2023-new outbreak of COVID-19 by classical drug dexamethasone: a potential fatality reducing agent
| Huvudupphovsmän: | , , , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
BMC
2023-05-01
|
| Serie: | Journal of Translational Medicine |
| Länkar: | https://doi.org/10.1186/s12967-023-04186-4 |